Richard Harris

Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.

Harris has traveled to all seven continents for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest, the foot of Mt. Kilimanjaro (for a story about tuberculosis), and Japan to cover the nuclear aftermath of the 2011 tsunami.
In 2010, Harris' reporting revealed that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. That revelation led the federal government to make a more realistic assessment of the extent of the spill.

Harris covered climate change for decades. He reported from the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, and including Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR's award-winning 2007-2008 "Climate Connections" series.

Over the course of his career, Harris has been the recipient of many prestigious awards. Those include the American Geophysical Union's 2013 Presidential Citation for Science and Society. He shared the 2009 National Academy of Sciences Communication Award and was a finalist again in 2011. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry. Since 1988, the American Association for the Advancement of Science has honored Harris three times with its science journalism award.

Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues related to the nuclear weapons lab in Livermore. He started his career as an AAAS Mass Media Science Fellow at the now-defunct Washington (DC) Star.

Harris is co-founder of the Washington, D.C., Area Science Writers Association, and is past president of the National Association of Science Writers. He serves on the board of the Council for the Advancement of Science Writing.

A California native, Harris returned to the University of California-Santa Cruz in 2012, to give a commencement address at Crown College, where he had given a valedictory address at his own graduation. He earned a bachelor's degree at the school in biology, with highest honors.

Pages

Shots - Health News
5:22 pm
Fri April 10, 2015

Clam Cancer Spreads Along Eastern Seaboard

The blood cancer in soft-shell clams poses no risk to humans, but it does kill the shellfish.
Pat Wellenbach AP

Originally published on Mon April 13, 2015 8:50 am

Not every clam is, as the expression goes, happy as a clam. Even shellfish, it turns out, can get cancer. And it just might be that this cancer is spread from clam to clam by rogue cells bobbing through the ocean, scientists reported Thursday in the journal Cell.

Read more
Shots - Health News
6:07 pm
Wed April 8, 2015

Link Between Heart Disease And Height Hidden In Our Genes

Originally published on Thu April 9, 2015 11:53 am

Shorter people are more likely than taller folks to have clogged heart arteries, and a new study says part of the reason lies in the genes.

Doctors have known since the 1950s about the link between short stature and coronary artery disease, "but the reason behind this really hasn't been completely clear," says Nilesh Samani, a cardiologist at the University of Leicester in the U.K.

Read more
Shots - Health News
4:49 pm
Mon March 23, 2015

Why The War On Cancer Hasn't Been Won

Vidhya Nagarajan for NPR

Originally published on Tue March 24, 2015 12:26 pm

When President Richard Nixon declared a war on cancer in 1971, there were high hopes that scientists were close enough to understanding the underlying causes that many cures were within reach.

We obviously haven't won the war.

In fact, a prominent cancer biologist argues that the conceptual framework for understanding cancer has come full circle over the past 40 years.

Read more
Shots - Health News
4:07 pm
Mon March 23, 2015

Stats Split On Progress Against Cancer

Find other stories in the Living Cancer series at WNYC.org.
WNYC

Originally published on Tue March 24, 2015 8:33 am

When someone asks whether we're winning the war on cancer, the discussion often veers into the world of numbers. And, depending on which numbers you're looking at, the answer can either be yes or no.

Let's start with the no.

The number of cancer deaths in this country is on the rise. It climbed 4 percent between 2000 and 2011, the latest year in official statistics. More than 577,000 people died of cancer in 2011. That's almost a quarter of all deaths. Those aren't just personal tragedies – the figure represents a growing burden on America.

Read more
Shots - Health News
6:03 pm
Wed March 11, 2015

Results Of Many Clinical Trials Not Being Reported

Glenn Lightner in 2012 at age 13. His father searched clinicaltrials.gov for years, to no avail, hoping to find a promising experimental cancer treatment that might save his son's life.
Courtesy of Lawrence Lightner

Originally published on Wed April 1, 2015 4:07 pm

Many scientists are failing to live up to a 2007 law that requires them to report the results of their clinical trials to a public website, according to a study in Thursday's New England Journal of Medicine.

Read more
Shots - Health News
4:16 pm
Thu February 19, 2015

A Biological Quest Leads To A New Kind Of Breast Cancer Drug

It's a good start when experimental compounds stop the proliferation of cancer cells in the lab. But, as many researchers have learned the hard way, that's just an early step toward creating a worthwhile treatment.
Science Source

Originally published on Thu February 19, 2015 8:13 pm

Each year, the Food and Drug Administration approves dozens of drugs, but often those medicines don't make a huge difference to people with disease. That's because these "new" drugs are often very much like existing medicines — or are, in fact, existing medicines, approved for a slightly different purpose.

But every now and then the FDA approves a truly new drug. And that's the story of Pfizer's palbociclib, brand name Ibrance, which the agency approved for the treatment of a common form of advanced breast cancer.

Read more
Shots - Health News
3:42 am
Thu February 12, 2015

Smoking's Death Toll May Be Higher Than Anyone Knew

Tobacco smokers are more likely than nonsmokers to die from infection, kidney disease and, maybe, breast cancer.
iStockphoto

Originally published on Thu February 12, 2015 9:09 am

The U.S. surgeon general lists 21 deadly diseases that are caused by smoking. Now, a study in this week's New England Journal of Medicine points to more than a dozen other diseases that apparently add to the tobacco death toll.

To arrive at this conclusion, scientists from the American Cancer Society, the National Cancer Institute and several universities tracked nearly a million people for a decade and recorded their causes of death.

Read more
Shots - Health News
4:04 pm
Thu February 5, 2015

FDA Commissioner Hamburg Grappled With Global Challenges

Dr. Margaret Hamburg will have served almost six years as FDA commissioner by the time she leaves, far longer than the recent tenure for chiefs of the agency.
J. David Ake AP

Originally published on Thu February 5, 2015 6:31 pm

Dr. Margaret Hamburg is stepping down from one of the toughest jobs in the federal government: commissioner of the Food and Drug Administration.

The agency regulates drugs and medical devices and has an important role in food safety. And it's a highly contentious job. No matter what you do, someone's going to complain that you're either too easy on industry or standing in the way of progress.

Read more
Goats and Soda
5:19 pm
Mon February 2, 2015

Lack Of Patients Hampers Ebola Drug And Vaccine Testing

A nurse administers an experimental Ebola vaccine Monday at Redemption Hospital in Monrovia, Liberia. Researchers aim to give shots to 27,000 people during the large trial.
John Moore Getty Images

Originally published on Wed February 4, 2015 11:39 am

On Monday, the first 12 volunteers received an experimental Ebola vaccine in Liberia, launching vaccine trials there. Over the next year or so, scientists hope to inject 27,000 volunteers. The goal is to test two different shots that could protect people from the deadly disease.

Read more
Shots - Health News
1:23 pm
Fri January 30, 2015

Obama Wants Funding For Research On More Precise Health Care

Harvard University student Elana Simon introduces President Obama before he spoke at the White House Friday about an initiative to encourage research into more precise medicine.
Mandel Ngan AFP/Getty Images

You may soon be able to donate your personal data to science. There are plans afoot to find 1 million Americans to volunteer for a new Precision Medicine Initiative that would anonymously link medical records, genetic readouts, details about an individual's gut bacteria, lifestyle information and maybe even data from your Fitbit.

Read more

Pages